{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:30:03Z","timestamp":1786350603028,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515012228"],"award-info":[{"award-number":["2021A1515012228"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Prod. Bioprospect."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s13659-026-00639-7","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:57:59Z","timestamp":1786348679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel tetrahydrocurcumin derivative as a potential anti-colorectal cancer agent: studies on its design, synthesis, and in vitro and in vivo biological evaluation"],"prefix":"10.1007","volume":"16","author":[{"given":"Yixin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meitao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"3","key":"639_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"639_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391. https:\/\/doi.org\/10.1136\/gutjnl-2015-310912.","journal-title":"Gut"},{"issue":"4","key":"639_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/01635581.2018.1464347","volume":"70","author":"K Doello","year":"2018","unstructured":"Doello K, Ortiz R, Alvarez PJ, Melguizo C, Cabeza L, Prados J. Latest in vitro and in vivo assay, clinical trials and patents in cancer treatment using curcumin: a literature review. Nutr Cancer. 2018;70(4):569\u201378. https:\/\/doi.org\/10.1080\/01635581.2018.1464347.","journal-title":"Nutr Cancer"},{"issue":"3","key":"639_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/187152006776930918","volume":"6","author":"S Singh","year":"2006","unstructured":"Singh S, Khar A. Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem. 2006;6(3):259\u201370. https:\/\/doi.org\/10.2174\/187152006776930918.","journal-title":"Anticancer Agents Med Chem"},{"issue":"8","key":"639_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/1061186X.2016.1157883","volume":"24","author":"W Liu","year":"2016","unstructured":"Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, et al. Oral bioavailability of curcumin: problems and advancements. J Drug Target. 2016;24(8):694\u2013702. https:\/\/doi.org\/10.3109\/1061186X.2016.1157883.","journal-title":"J Drug Target"},{"issue":"12","key":"639_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3109\/00498257809069589","volume":"8","author":"GM Holder","year":"2016","unstructured":"Holder GM, Plummer JL, Ryan AJ. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica. 2016;8(12):761\u20138. https:\/\/doi.org\/10.3109\/00498257809069589.","journal-title":"Xenobiotica"},{"issue":"12","key":"639_CR7","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/mnfr.201100290","volume":"55","author":"CS Lai","year":"2011","unstructured":"Lai CS, Wu JC, Yu SF, Badmaev V, Nagabhushanam K, Ho CT, et al. Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Mol Nutr Food Res. 2011;55(12):1819\u201328. https:\/\/doi.org\/10.1002\/mnfr.201100290.","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"639_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0090-9556(24)15211-7","volume":"27","author":"MH Pan","year":"1999","unstructured":"Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos. 1999;27(4):486\u201394.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"639_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2116\/bunsekikagaku.57.257","volume":"57","author":"K Sato","year":"2008","unstructured":"Sato K, Iki N, Takahshi T, Hoshino H. Evaluation of stability against oxidation and acid dissociation properties for tetrahydrocurcumin in aqueous solution. Bunseki Kagaku. 2008;57(4):257\u201363. https:\/\/doi.org\/10.2116\/bunsekikagaku.57.257.","journal-title":"Bunseki Kagaku"},{"issue":"6","key":"639_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/jphp.12891","volume":"70","author":"X Zhang","year":"2018","unstructured":"Zhang X, Peng L, Liu A, Ji J, Zhao L, Zhai G. The enhanced effect of tetrahydrocurcumin on radiosensitivity of glioma cells. J Pharm Pharmacol. 2018;70(6):749\u201359. https:\/\/doi.org\/10.1111\/jphp.12891.","journal-title":"J Pharm Pharmacol"},{"issue":"13","key":"639_CR11","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3748\/wjg.14.2003","volume":"14","author":"P Yoysungnoen","year":"2008","unstructured":"Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol. 2008;14(13):2003\u20139. https:\/\/doi.org\/10.3748\/wjg.14.2003.","journal-title":"World J Gastroenterol"},{"issue":"53","key":"639_CR12","doi-asserted-by":"publisher","first-page":"91134","DOI":"10.18632\/oncotarget.19845","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liu Y, Zou J, Yan L, Du W, Zhang Y, et al. Tetrahydrocurcumin induces mesenchymal-epithelial transition and suppresses angiogenesis by targeting HIF-1\u03b1 and autophagy in human osteosarcoma. Oncotarget. 2017;8(53):91134\u201349. https:\/\/doi.org\/10.18632\/oncotarget.19845.","journal-title":"Oncotarget"},{"key":"639_CR13","doi-asserted-by":"publisher","first-page":"391748","DOI":"10.1155\/2015\/391748","volume":"2015","author":"B Yoysungnoen","year":"2015","unstructured":"Yoysungnoen B, Bhattarakosol P, Patumraj S, Changtam C. Effects of tetrahydrocurcumin on hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor expression in cervical cancer cell-induced angiogenesis in nude mice. Biomed Res Int. 2015;2015:391748. https:\/\/doi.org\/10.1155\/2015\/391748.","journal-title":"Biomed Res Int"},{"key":"639_CR14","doi-asserted-by":"publisher","first-page":"30616","DOI":"10.3402\/fnr.v60.30616","volume":"60","author":"X Han","year":"2016","unstructured":"Han X, Deng S, Wang N, Liu Y, Yang X. Inhibitory effects and molecular mechanisms of tetrahydrocurcumin against human breast cancer MCF-7 cells. Food Nutr Res. 2016;60:30616.","journal-title":"Food Nutr Res"},{"key":"639_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.fct.2014.02.024","volume":"67","author":"N Kang","year":"2014","unstructured":"Kang N, Wang MM, Wang YH, Zhang ZN, Cao HR, Lv YH, et al. Tetrahydrocurcumin induces G2\/M cell cycle arrest and apoptosis involving p38 MAPK activation in human breast cancer cells. Food Chem Toxicol. 2014;67:193\u2013200. https:\/\/doi.org\/10.1016\/j.fct.2014.02.024.","journal-title":"Food Chem Toxicol"},{"issue":"9","key":"639_CR16","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1039\/c7fo00484b","volume":"8","author":"W Liu","year":"2017","unstructured":"Liu W, Zhang Z, Lin G, Luo D, Chen H, Yang H, et al. Tetrahydrocurcumin is more effective than curcumin in inducing the apoptosis of H22 cells via regulation of a mitochondrial apoptosis pathway in ascites tumor-bearing mice. Food Funct. 2017;8(9):3120\u20139. https:\/\/doi.org\/10.1039\/c7fo00484b.","journal-title":"Food Funct"},{"issue":"6","key":"639_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13659-017-0143-9","volume":"7","author":"A Mahal","year":"2017","unstructured":"Mahal A, Wu P, Jiang ZH, Wei X. Synthesis and cytotoxic activity of novel tetrahydrocurcumin derivatives bearing pyrazole moiety. Nat Prod Bioprospect. 2017;7(6):461\u20139. https:\/\/doi.org\/10.1007\/s13659-017-0143-9.","journal-title":"Nat Prod Bioprospect"},{"issue":"3","key":"639_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/acs.jmedchem.6b00788","volume":"60","author":"PA Jackson","year":"2017","unstructured":"Jackson PA, Widen JC, Harki DA, Brummond KM. Covalent modifiers: a chemical perspective on the reactivity of \u03b1, \u03b2-unsaturated carbonyls with thiols via hetero-Michael addition reactions. J Med Chem. 2017;60(3):839\u201385. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00788.","journal-title":"J Med Chem"},{"key":"639_CR19","doi-asserted-by":"publisher","first-page":"104187","DOI":"10.1016\/j.bioorg.2020.104187","volume":"103","author":"M Huang","year":"2020","unstructured":"Huang M, Gong P, Wang Y, Xie X, Ma Z, Xu Q, et al. Synthesis and antitumor effects of novel 18\u03b2-glycyrrhetinic acid derivatives featuring an exocyclic \u03b1, \u03b2-unsaturated carbonyl moiety in ring A. Bioorg Chem. 2020;103:104187. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104187.","journal-title":"Bioorg Chem"},{"key":"639_CR20","doi-asserted-by":"publisher","first-page":"104941","DOI":"10.1016\/j.bioorg.2021.104941","volume":"112","author":"W Cai","year":"2021","unstructured":"Cai W, Li J, Chen C, Wu J, Li J, Xue X. Design, synthesis, and anticancer evaluation of novel andrographolide derivatives bearing an \u03b1, \u03b2-unsaturated ketone moiety. Bioorg Chem. 2021;112:104941. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104941.","journal-title":"Bioorg Chem"},{"key":"639_CR21","doi-asserted-by":"publisher","first-page":"104036","DOI":"10.1016\/j.bioorg.2020.104036","volume":"101","author":"SS Wang","year":"2020","unstructured":"Wang SS, Zhang QL, Chu P, Kong LQ, Li GZ, Li YQ, et al. Synthesis and antitumor activity of \u03b1, \u03b2-unsaturated carbonyl moiety- containing oleanolic acid derivatives targeting PI3K\/AKT\/mTOR signaling pathway. Bioorg Chem. 2020;101:104036. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104036.","journal-title":"Bioorg Chem"},{"issue":"9","key":"639_CR22","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1021\/jm000008j","volume":"43","author":"T Honda","year":"2000","unstructured":"Honda T, Gribble GW, Suh N, Finlay HJ, Rounds BV, Bore L, et al. Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages. J Med Chem. 2000;43(9):1866\u201377. https:\/\/doi.org\/10.1021\/jm000008j.","journal-title":"J Med Chem"},{"key":"639_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ejmech.2015.07.004","volume":"101","author":"L Heller","year":"2015","unstructured":"Heller L, Schwarz S, Per V, Kowitsch A, Siewert B, Csuk R. Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids. Eur J Med Chem. 2015;101:391\u20139. https:\/\/doi.org\/10.1016\/j.ejmech.2015.07.004.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"639_CR24","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bmcl.2015.12.013","volume":"26","author":"PK Sahu","year":"2016","unstructured":"Sahu PK, Sahu PK, Sahu PL, Agarwal DD. Structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives. Bioorg Med Chem Lett. 2016;26(4):1342\u20137. https:\/\/doi.org\/10.1016\/j.bmcl.2015.12.013.","journal-title":"Bioorg Med Chem Lett"},{"issue":"34","key":"639_CR25","doi-asserted-by":"publisher","first-page":"15628","DOI":"10.1039\/d5sc03429a","volume":"16","author":"D Feng","year":"2025","unstructured":"Feng D, Li X, Liu J, Shao X, Liu L, Shi Y, et al. Selectively triggered: ROS-activated Michael acceptor prodrug strategy to enhance tumor targeting efficacy. Chem Sci. 2025;16(34):15628\u201337. https:\/\/doi.org\/10.1039\/d5sc03429a.","journal-title":"Chem Sci"},{"issue":"12","key":"639_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","volume":"21","author":"L Boike","year":"2022","unstructured":"Boike L, Henning NJ, Nomura DK. Advances in covalent drug discovery. Nat Rev Drug Discov. 2022;21(12):881\u201398. https:\/\/doi.org\/10.1038\/s41573-022-00542-z.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"639_CR27","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.3390\/ijms25116099","volume":"25","author":"CMC Andr\u00e9s","year":"2024","unstructured":"Andr\u00e9s CMC, P\u00e9rez De La Lastra JM, Bustamante Munguira E, Andr\u00e9s Juan C, P\u00e9rez-Lebe AE. Michael acceptors as anti-cancer compounds: coincidence or causality? Int J Mol Sci. 2024;25(11):6099. https:\/\/doi.org\/10.3390\/ijms25116099.","journal-title":"Int J Mol Sci"},{"key":"639_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1074","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003. https:\/\/doi.org\/10.1038\/nrc1074.","journal-title":"Nat Rev Cancer"},{"key":"639_CR29","doi-asserted-by":"publisher","first-page":"216965","DOI":"10.1016\/j.canlet.2024.216965","volume":"594","author":"C Palominos","year":"2024","unstructured":"Palominos C, Fuentes-Retamal S, Salazar JP, Guzm\u00e1n-Rivera D, Correa P, Mellado M, et al. Mitochondrial bioenergetics as a cell fate rheostat for responsive to Bcl-2 drugs: new cues for cancer chemotherapy. Cancer Lett. 2024;594:216965. https:\/\/doi.org\/10.1016\/j.canlet.2024.216965.","journal-title":"Cancer Lett"},{"issue":"1","key":"639_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41389-024-00516-3","volume":"13","author":"D Leiva","year":"2024","unstructured":"Leiva D, Lucendo E, Garc\u00eda-Jare O AB, Sancho M, Orz\u00e1ez M. Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain. Oncogenesis. 2024;13(1):14. https:\/\/doi.org\/10.1038\/s41389-024-00516-3.","journal-title":"Oncogenesis"},{"issue":"7","key":"639_CR31","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1002\/jcp.26333","volume":"233","author":"A Chidambaram","year":"2018","unstructured":"Chidambaram A, Sundararaju K, Chidambaram RK, Subbiah R, Jayaraj JM, Muthusamy K, et al. Design, synthesis, and characterization of \u03b1, \u03b2-unsaturated carboxylic acid, and its urea based derivatives that explores novel epigenetic modulators in human non-small cell lung cancer A549 cell line. J Cell Physiol. 2018;233(7):5293\u2013309. https:\/\/doi.org\/10.1002\/jcp.26333.","journal-title":"J Cell Physiol"},{"key":"639_CR32","doi-asserted-by":"publisher","first-page":"111687","DOI":"10.1016\/j.ejmech.2019.111687","volume":"183","author":"M Hossain","year":"2019","unstructured":"Hossain M, Das U, Dimmock JR. Recent advances in \u03b1,\u03b2-unsaturated carbonyl compounds as mitochondrial toxins. Eur J Med Chem. 2019;183:111687. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111687.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"639_CR33","first-page":"21","volume":"4","author":"M Rozencweig","year":"1981","unstructured":"Rozencweig M, Von Hoff DD, Staquet MJ, Schein PS, Penta JS, Goldin A, et al. Animal toxicology for early clinical trials with anticancer agents. Cancer Clin Trials. 1981;4(1):21\u20138.","journal-title":"Cancer Clin Trials"},{"issue":"1","key":"639_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/s12885-017-3677-7","volume":"17","author":"WJ Aston","year":"2017","unstructured":"Aston WJ, Hope DE, Nowak AK, Robinson BW, Lake RA, Lesterhuis WJ. A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. BMC Cancer. 2017;17(1):684. https:\/\/doi.org\/10.1186\/s12885-017-3677-7.","journal-title":"BMC Cancer"},{"key":"639_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22050756","author":"C Wang","year":"2017","unstructured":"Wang C, Huo X, Gao L, Sun G, Cao L. Hepatoprotective effect of carboxymethyl Pachyman in fluorouracil-treated CT26-bearing mice. Molecules. 2017. https:\/\/doi.org\/10.3390\/molecules22050756.","journal-title":"Molecules"},{"key":"639_CR36","doi-asserted-by":"publisher","first-page":"D277","DOI":"10.1093\/nar\/gkh063","volume":"32","author":"M Kanehisa","year":"2004","unstructured":"Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucl Acids Res. 2004;32:D277\u201380. https:\/\/doi.org\/10.1093\/nar\/gkh063.","journal-title":"Nucl Acids Res"},{"issue":"4","key":"639_CR37","doi-asserted-by":"publisher","first-page":"5964","DOI":"10.3892\/mmr.2018.8600","volume":"17","author":"G Song","year":"2018","unstructured":"Song G, Lu H, Chen F, Wang Y, Fan W, Shao W, et al. Tetrahydrocurcumin-induced autophagy via suppression of PI3K\/Akt\/mTOR in non-small cell lung carcinoma cells. Mol Med Rep. 2018;17(4):5964\u20139. https:\/\/doi.org\/10.3892\/mmr.2018.8600.","journal-title":"Mol Med Rep"},{"issue":"11","key":"639_CR38","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mnfr.201100454","volume":"55","author":"J Wu","year":"2011","unstructured":"Wu J, Lai C, Badmaev V, Nagabhushanam K, Ho C, Pan M. Tetrahydrocurcumin , a major metabolite of curcumin , induced autophagic cell death through coordinative modulation of PI3K\/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Mol Nutr Food Res. 2011;55(11):1646\u201354. https:\/\/doi.org\/10.1002\/mnfr.201100454.","journal-title":"Mol Nutr Food Res"},{"key":"639_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2023.113603","author":"J Wang","year":"2023","unstructured":"Wang J, Wang D, Feng L, Li X, Gong Y, Wang Z, et al. Eremophilane-type and xanthanolide-type sesquiterpenes from the aerial parts of Xanthium sibiricum and their anti-inflammatory activities. Phytochemistry. 2023. https:\/\/doi.org\/10.1016\/j.phytochem.2023.113603.","journal-title":"Phytochemistry"},{"issue":"1","key":"639_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/or.2016.4820","volume":"36","author":"Y Mao","year":"2016","unstructured":"Mao Y, Xi L, Li Q, Cai Z, Lai Y, Zhang X, et al. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K\/Akt pathway via Polo-like kinase 1. Oncol Rep. 2016;36(1):49\u201356. https:\/\/doi.org\/10.3892\/or.2016.4820.","journal-title":"Oncol Rep"},{"issue":"5","key":"639_CR41","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1158\/1535-7163.MCT-13-0639","volume":"13","author":"R Dienstmann","year":"2014","unstructured":"Dienstmann R, Rodon J, Serra V, Tabernero J. Picking the point of inhibition: a comparative review of PI3K\/AKT\/mTOR pathway inhibitors. Mol Cancer Ther. 2014;13(5):1021\u201331. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0639.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"639_CR42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/01.cad.0000173476.67239.3b","volume":"16","author":"D Morgensztern","year":"2005","unstructured":"Morgensztern D, Mcleod HL. PI3K\/Akt\/mTOR pathway as a target for cancer therapy. Anticancer Drugs. 2005;16(8):797\u2013803. https:\/\/doi.org\/10.1097\/01.cad.0000173476.67239.3b.","journal-title":"Anticancer Drugs"},{"key":"639_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","volume":"698","author":"S Noorolyai","year":"2019","unstructured":"Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K\/AKT signalling pathway and cancer. Gene. 2019;698:120\u20138. https:\/\/doi.org\/10.1016\/j.gene.2019.02.076.","journal-title":"Gene"}],"container-title":["Natural Products and Bioprospecting"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-026-00639-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13659-026-00639-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-026-00639-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:58:00Z","timestamp":1786348680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13659-026-00639-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["639"],"URL":"https:\/\/doi.org\/10.1007\/s13659-026-00639-7","relation":{},"ISSN":["2192-2195","2192-2209"],"issn-type":[{"value":"2192-2195","type":"print"},{"value":"2192-2209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"80"}}